Elevation Oncology, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/14/2025 | 5.99 M | $2.20 M | 0.00% | 10.13% |
| BML CAPITAL MANAGEMENT, LLC | 08/11/2025 | 5.89 M | $2.16 M | -0.01% | 9.95% |
| AISLING CAPITAL MANAGEMENT LP | 08/13/2025 | 2.83 M | $1.04 M | 0.00% | 4.79% |
| VANGUARD GROUP INC | 08/11/2025 | 2.26 M | $828.21 K | -12.71% | 3.81% |
| OPALEYE MANAGEMENT INC. | 08/15/2025 | 1.44 M | $529.38 K | 100.00% | 2.44% |
| DELTEC ASSET MANAGEMENT LLC | 07/18/2025 | 1.44 M | $527.29 K | 100.00% | 2.43% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2025 | 1.42 M | $522.91 K | 100.00% | 2.41% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 1.01 M | $370.88 K | 1,376.26% | 1.71% |
| RANGELEY CAPITAL, LLC | 08/14/2025 | 905.29 K | $332.33 K | 100.00% | 1.53% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/13/2025 | 597.02 K | $219.00 K | 100.00% | 1.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 538.66 K | $197.80 K | -54.59% | 0.91% |
| BLACKROCK, INC. | 08/12/2025 | 369.05 K | $135.48 K | -88.39% | 0.62% |
| DIADEMA PARTNERS LP | 08/14/2025 | 362.94 K | $133.23 K | 100.00% | 0.61% |
| CITADEL ADVISORS LLC | 08/14/2025 | 355.20 K | $130.40 K | 100.00% | 0.60% |
| SPHERA FUNDS MANAGEMENT LTD. | 08/14/2025 | 328.56 K | $120.62 K | -8.37% | 0.56% |
| GTS SECURITIES LLC | 08/08/2025 | 300.03 K | $110.11 K | 100.00% | 0.51% |
| PALUMBO WEALTH MANAGEMENT LLC | 07/15/2025 | 295.33 K | $108.42 K | 6.23% | 0.50% |
| AMERIPRISE FINANCIAL INC | 08/14/2025 | 294.33 K | $108.05 K | -1.49% | 0.50% |
| YAKIRA CAPITAL MANAGEMENT, INC. | 08/13/2025 | 263.10 K | $96.58 K | 100.00% | 0.44% |
| JANE STREET GROUP, LLC | 08/14/2025 | 255.44 K | $93.77 K | 465.25% | 0.43% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2025 | 254.30 K | $93.35 K | 31.07% | 0.43% |
| GOLDMAN SACHS GROUP INC | 08/14/2025 | 224.16 K | $82.29 K | 192.46% | 0.38% |
| UBS GROUP AG | 08/14/2025 | 201.66 K | $74.01 K | 73.17% | 0.34% |
| PENDERFUND CAPITAL MANAGEMENT LTD. | 08/14/2025 | 195.70 K | $71.84 K | 100.00% | 0.33% |
| STATE STREET CORP | 08/14/2025 | 194.80 K | $71.51 K | -81.56% | 0.33% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2025 | 165.83 K | $60.88 K | -74.38% | 0.28% |
| MARSHALL WACE, LLP | 08/13/2025 | 154.79 K | $57.27 K | 100.00% | 0.26% |
| EXOME ASSET MANAGEMENT LLC | 08/15/2025 | 110.35 K | $40.51 K | 100.00% | 0.19% |
| TWO SIGMA ADVISERS, LP | 08/14/2025 | 107.40 K | $39.43 K | -44.38% | 0.18% |
| NORTHERN TRUST CORP | 08/13/2025 | 90.91 K | $33.37 K | -80.17% | 0.15% |
| PERSISTENT ASSET PARTNERS LTD | 08/11/2025 | 83.42 K | $30.62 K | 100.00% | 0.14% |
| VERITION FUND MANAGEMENT LLC | 08/14/2025 | 76.50 K | $28.08 K | -82.54% | 0.13% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2025 | 67.38 K | $24.73 K | 100.00% | 0.11% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2025 | 51.67 K | $18.97 K | -10.18% | 0.09% |
| VIRTU FINANCIAL LLC | 08/12/2025 | 50.32 K | $18.00 K | 100.00% | 0.09% |
| CITADEL ADVISORS LLC | 08/14/2025 | 50.00 K | $18.36 K | -23.08% | 0.08% |
| FMR LLC | 08/14/2025 | 48.87 K | $17.94 K | 307.81% | 0.08% |
| NATIONAL BANK OF CANADA /FI/ | 08/18/2025 | 40.00 K | $14.68 K | 33.33% | 0.07% |
| HRT FINANCIAL LP | 08/14/2025 | 38.24 K | $14.00 K | 100.00% | 0.06% |
| ABEL HALL, LLC | 07/23/2025 | 32.80 K | $12.04 K | 100.00% | 0.06% |
| CSS LLC/IL | 08/14/2025 | 30.00 K | $11.01 K | 100.00% | 0.05% |
| NUVEEN, LLC | 08/12/2025 | 23.91 K | $8.78 K | -86.27% | 0.04% |
| SIMPLEX TRADING, LLC | 08/05/2025 | 22.78 K | $8.00 K | 15.75% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/15/2025 | 17.72 K | $6.51 K | -8.20% | 0.03% |
| MORGAN STANLEY | 08/15/2025 | 16.61 K | $6.10 K | -81.36% | 0.03% |
| Y-INTERCEPT (HONG KONG) LTD | 08/01/2025 | 14.02 K | $5.15 K | 100.00% | 0.02% |
| CITIGROUP INC | 08/11/2025 | 13.44 K | $4.94 K | -83.19% | 0.02% |
| TWO SIGMA SECURITIES, LLC | 08/14/2025 | 12.72 K | $4.67 K | -32.61% | 0.02% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2025 | 12.32 K | $4.52 K | 100.00% | 0.02% |
| FNY INVESTMENT ADVISERS, LLC | 07/30/2025 | 10.00 K | $3.00 K | 100.00% | 0.02% |
Elevation Oncology, Inc. institutional Ownership - FAQ's
During the previous two years, 67 institutional investors and hedge funds held shares of Elevation Oncology, Inc.. The most heavily invested institutionals were:
UBS Group AG: 0
Frazier Life Sciences Management, L.P.: 0
WELLS FARGO & COMPANY/MN: 0
Archer Investment Corp: 0
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO: 0
CITIGROUP INC: 0
49.92% of Elevation Oncology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.67 M shares in the last 24 months. This purchase volume represents approximately $989.52 K in transactions.